In contrast, MARCH5 protein levels were remarkably decreased in Stage IV tissues, consistent to MARCH5 mRNA expression (Fig. 1a), while MARCH5 protein expression in surrounding non-tumor tissues of Stage IV remained unchanged. The gene discussed is MARCHF5; the disease is neoplasm.